|Targets||Sphingosine 1 Phosphate Receptor|
|Description||CYM 50308 has been found to be an effective and selective S1P4 agonist.|
|Purity||≥98% by HPLC|
|Synonyms||CYM-50308; CYM 50308; CYM50308. (2Z,5Z)-5-[[1-(2,4-Difluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]methylene]-2-[(2-methoxyethyl)imino]-3-methyl-4-thiazolidinone|
The hydrochloride salt form of CYM 50358, which has been found to be an effective S1P4 antagonist.
CS-0777 is a selective sphingosine 1-phosphate receptor modulator agonist. It is in clinical trials for the treatment of multiple sclerosis, but no recent devel...
CYM 50260 has been found to be a S1P4 agonist.
This active molecular is a S1P1/S1P5 agonist with limited activity at S1P3. AMG 369 has no activity at S1P2 and S1P4. AMG-369 is shown to reduce blood lymphocyt...
This active molecular is a selective S1P1 receptor agonist that originated by Bristol-Myers Squibb. BMS-520 shows really good efficacy in animal models of arthr...
CYM 50308 has been found to be an effective and selective S1P4 agonist.
The hydrochloride salt form of PF-543, a novel SphK1 inhibitor that could exhibit activity in induceing necrosis in human colorectal cancer cells in biological ...
JTE 013 has been found to be an antagonist of Sphingosine-1-Phosphate Receptor-2 (S1P2R).